Drugs that contain Pasireotide Pamoate

1. Drug name - SIGNIFOR LAR KIT

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents protects the active chemical substance. Only patent owner can launch products that use this active substance.
US7473761 RECORDATI RARE Somatostatin analogues
Dec, 2026

(4 years from now)

These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8822637 RECORDATI RARE Somatostatin analogues
Aug, 2023

(7 months from now)

US7759308 RECORDATI RARE Microparticles comprising somatostatin analogues
Oct, 2026

(3 years from now)

US9351923 RECORDATI RARE Extended-release composition comprising a somatostatin derivative in microparticles
May, 2028

(5 years from now)

Exclusivity Exclusivity Expiration
Orphan Drug Exclusivity (ODE) Jun 29, 2025

Market Authorisation Date: 15 December, 2014

Treatment: Method of treating acromegaly

Dosage: FOR SUSPENSION;INTRAMUSCULAR

More Information on Dosage
Strength Dosage Availability
EQ 10MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 20MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 30MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 40MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription
EQ 60MG BASE/VIAL FOR SUSPENSION;INTRAMUSCULAR Prescription

availability in other generic markets.

Click on the highlighted region to filter.